Colostrum
Compiled from published pharmacological and botanical literature. Not independently verified by Herbuno. Spotted an error or have a correction? Flag it below →
| Compound Class | A whole biological matrix — first-milking mammary secretion. Not a molecule; no CAS applies |
| Key Components | Immunoglobulins (IgG dominant), lactoferrin, growth factors (IGF-1, TGF-β), lysozyme, lactoperoxidase, oligosaccharides, cytokines |
| Source | Bovine, collected within the first ~24–72 hours post-parturition. IgG content falls steeply with each subsequent milking |
| Typical Standardisation | IgG content by ELISA or RID — the meaningful spec; commonly 15–40% grades |
| Primary Applications | Upper respiratory tract symptom reduction; gut barrier and GI formulation; sports nutrition |
| ⚠ Allergen | Bovine milk product — a major regulated dairy allergen requiring declaration |
| Claim Strength (Overview) | Moderate for URTI incidence in exercising adults (meta-analysed); Emerging for gut-barrier claims |
| Buy from Herbuno | Colostrum Powder → |
Name origin: Colostrum, from the Latin, denotes the first milk secreted by the mammary gland after parturition — a compositionally distinct fluid, not merely concentrated milk. It is dense in immunoglobulins (IgG dominant in bovines), lactoferrin, growth factors, lysozyme, lactoperoxidase, oligosaccharides and cytokines, and its composition changes rapidly: IgG content falls steeply with each successive milking, which is why collection window is a specification and not a detail. Traditional use: Colostrum has been valued in Ayurvedic practice (as piyush) and in dairy cultures generally, though its use as an isolated supplement is modern. Its biological purpose is unambiguous: in ruminants, the calf is born essentially agammaglobulinaemic and acquires passive immunity entirely through colostral IgG absorbed across a transiently permeable gut. Research trajectory: That biological purpose raises the obvious question for a human supplement — the adult human gut is not transiently permeable to intact immunoglobulins, and orally administered bovine IgG is not absorbed systemically in any meaningful quantity. This is not a fatal objection, but it does mean that the mechanism must be local rather than systemic, and any honest page must say so. The clinical literature has concentrated on upper respiratory symptoms in exercising adults, and on gut barrier function. Commercial source: Bovine first-milking colostrum, spray-dried, typically standardised on IgG.
Evidence for Colostrum Applications
The upper-respiratory evidence has been meta-analysed and the effect is meaningful, though the evidence base is small. A systematic review and meta-analysis of randomised controlled trials in healthy adults searched ten databases and identified five trials (152 participants), all in individuals engaged in regular exercise training; over an 8–12 week follow-up, bovine colostrum compared with placebo significantly reduced the incidence rate of upper respiratory symptom days (rate ratio 0.56, 95% CI 0.43–0.72, p<0.001) and episodes (0.62, 95% CI 0.40–0.99, p=0.04) — reductions of 44% and 38% respectively (Jones 2016). The authors were themselves appropriately cautious: the point estimates exceed the smallest clinically important difference, but the low precision of individual study estimates means an adequately powered trial is still needed. 152 participants across five trials is a thin base for a 44% claim. Claim strength: Moderate.
The finding has been partially extended beyond athletes. A randomized, triple-blind, placebo-controlled trial supplemented medical and health-science students — two populations differing in pathogen exposure — with a relatively low dose of 0.5–1.0 g/day of bovine colostrum or placebo over 45 days and again over 7 days, across a 107-day trial, monitoring self-reported URTI symptom frequency and severity; a significant level of protection from URTIs was observed, expressed as a drop in symptomatic days in the colostrum group among the higher-exposure medical students (Nutrients 2023). Note that the outcome was self-reported symptoms, not confirmed infection. Claim strength: Moderate.
The mechanism must be understood as local, not systemic, and a supplier who blurs this is misleading their customer. Orally administered bovine IgG is not absorbed intact into adult human circulation in meaningful quantity — the transient gut permeability that allows passive immune transfer in the neonatal calf does not exist in the adult human. What bovine IgG can plausibly do is act within the gut lumen: binding and neutralising enteric pathogens and toxins, agglutinating bacteria, and modulating the mucosal immune interface. That is a coherent mechanism. It is not "colostrum boosts your immune system" in the systemic sense the marketing implies. Claim strength: High (established immunology).
Colostrum is compositionally a matrix rather than an active, and this cuts both ways. Beyond IgG it delivers lactoferrin (which has its own monograph in this index, with genuine iron-deficiency evidence), growth factors including IGF-1 and TGF-β, lysozyme, lactoperoxidase and oligosaccharides. This means colostrum plausibly does several things at once, and it also means that attributing an observed effect to any one component is not straightforward. The IGF-1 content in particular is frequently used in marketing as an anabolic claim — but orally ingested IGF-1 is a peptide subject to gastric proteolysis, and evidence for systemic IGF-1 elevation from colostrum is weak. Claim strength: Emerging.
The gut-barrier proposition is mechanistically attractive and clinically underpowered, and it should be described that way. Colostral growth factors, particularly TGF-β, plausibly support intestinal epithelial proliferation and tight-junction integrity, and preliminary work has examined colostrum in exercise-induced intestinal permeability and in NSAID-associated gut injury. This is a reasonable research direction. It is not, at present, a claim a formulator can make with confidence, and presenting "leaky gut" repair as an established colostrum benefit would run well ahead of the data. Claim strength: Emerging.
Dosage & Formulator Specification
Herbuno carries Colostrum Powder. Buyers should specify the required IgG content, which is the meaningful standardisation for this ingredient, and should note that colostrum is a bovine milk product and a major regulated dairy allergen requiring clear declaration.
Trial dosing spans a wide range and the low end is more interesting than commonly assumed. The athlete URTI trials generally used doses in the region of 10–20 g/day, but the student trial found a significant protective signal at just 0.5–1.0 g/day — an order of magnitude lower — which if it replicates has real cost implications for a formulator. Benefit in both settings emerged over weeks (8–12 weeks in the athlete trials), not acutely. Because the mechanism is luminal, colostrum should be taken in a way that maximises gut contact; heavy heat processing should be avoided, since immunoglobulins are heat-labile proteins.
Analytical verification should centre on IgG by ELISA or radial immunodiffusion — this is the specification that matters and a bare "colostrum powder" designation does not capture it. Collection window must be documented, since IgG falls steeply with each milking after parturition and "colostrum" collected at the fourth milking is closer to transitional milk. Processing temperature history is critical: immunoglobulins are heat-labile, and a material can pass a protein assay while its IgG is denatured and functionally inert — request functional or ELISA-based IgG data rather than crude protein. Standard dairy microbiological testing, antibiotic residue screening, and dairy-allergen declaration apply.
Bovine colostrum has an extensive safety record and is well tolerated; gastrointestinal effects (bloating, loose stools) are the most commonly reported and are generally mild. Several points require plain statement. It is a bovine milk product and therefore a major regulated allergen — it must be declared and is contraindicated in cow’s-milk-protein allergy; individuals with lactose intolerance may also react depending on the lactose content of the grade. The IGF-1 content is real, and while oral IGF-1 is subject to gastric proteolysis and systemic elevation is not well supported, formulators should be aware that IGF-1 claims attract regulatory attention and that colostrum appears on some sporting anti-doping watchlists precisely because of it. Finally, the URTI evidence base — five trials, 152 participants — is thin, and the meta-analysts themselves called for an adequately powered trial. That should temper the confidence of any claim built on it.
Frequently Asked Questions — Colostrum
Does colostrum reduce respiratory infections?
The meta-analysis is positive but the base is thin. Five trials, 152 participants, all in exercising adults: bovine colostrum reduced upper respiratory symptom days by 44% (rate ratio 0.56) and episodes by 38%. But the meta-analysts themselves noted low precision in the individual estimates and called for an adequately powered trial. Treat it as promising, not settled.
Does colostrum IgG get absorbed into the bloodstream?
No, and this is where the marketing misleads. The transient gut permeability that lets a newborn calf absorb colostral IgG does not exist in the adult human. What bovine IgG can plausibly do is act in the gut lumen — binding enteric pathogens and toxins, agglutinating bacteria, modulating the mucosal interface. That is a real mechanism. It is not systemic immune boosting.
What dose is needed?
Possibly far less than the market assumes. Athlete trials generally used 10-20 g/day, but a triple-blind student trial found significant protection at just 0.5-1.0 g/day — an order of magnitude lower. If that replicates it has real cost implications. Benefit emerged over 8-12 weeks in either case, not acutely.
What should I specify when buying colostrum?
IgG content by ELISA or radial immunodiffusion, plus the collection window and the processing temperature history. IgG falls steeply with each milking after parturition, and immunoglobulins are heat-labile — a material can pass a crude protein assay while its IgG is denatured and functionally inert.
Related compounds: Lactoferrin, Immunoglobulin Y, Beta-Glucans, Polysaccharides
Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.
← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery